NASDAQ:OCEA

Ocean Biomedical (OCEA) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$1.44
$1.57
50-Day Range
N/A
52-Week Range
N/A
Volume
128,828 shs
Average Volume
367,789 shs
Market Capitalization
$54.05 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$17.63

Ocean Biomedical MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
1,030.1% Upside
$17.63 Price Target
Short Interest
Bearish
8.01% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.25 out of 5 stars

Medical Sector

562nd out of 928 stocks

Pharmaceutical Preparations Industry

268th out of 431 stocks

About Ocean Biomedical

Aesther Healthcare Acquisition Corp. entered into definitive merger agreement with Ocean Biomedical, Inc.

OCEA Stock News Headlines

Ocean Biomedical, Inc. (OCEA)
AGW-Mental Wellbeing 2024 - Mid-size companies
OCEA May 2024 7.500 call
OCEA May 2024 2.500 put
OCEA Mar 2024 10.000 put
OCEA Apr 2024 10.000 call
See More Headlines
Receive OCEA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ocean Biomedical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
5/15/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:OCEA
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$17.63
High Stock Price Target
$17.63
Low Stock Price Target
$17.63
Potential Upside/Downside
+1,030.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-960,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
($2.26) per share

Miscellaneous

Free Float
9,182,000
Market Cap
$54.05 million
Optionable
Optionable
Beta
1.64
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

OCEA Stock Analysis - Frequently Asked Questions

Should I buy or sell Ocean Biomedical stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Ocean Biomedical in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" OCEA shares.
View OCEA analyst ratings
or view top-rated stocks.

What is Ocean Biomedical's stock price target for 2024?

1 Wall Street analysts have issued 1 year target prices for Ocean Biomedical's stock. Their OCEA share price targets range from $17.63 to $17.63. On average, they expect the company's stock price to reach $17.63 in the next year. This suggests a possible upside of 1,030.1% from the stock's current price.
View analysts price targets for OCEA
or view top-rated stocks among Wall Street analysts.

When did Ocean Biomedical IPO?

Ocean Biomedical (OCEA) raised $22 million in an initial public offering (IPO) on the week of April 18th 2022. The company issued 2,000,000 shares at a price of $10.00-$12.00 per share. Roth Capital Partners and JonesTrading served as the underwriters for the IPO.

This page (NASDAQ:OCEA) was last updated on 5/15/2024 by MarketBeat.com Staff

From Our Partners